Results 241 to 250 of about 67,942 (278)

Hydrogel‐based drug delivery systems for intracerebral hemorrhage with therapeutic advances and emerging roles of the bone–brain axis

open access: yesInterdisciplinary Medicine, EarlyView.
Hydrogel‐based drug delivery systems offer a promising approach for treating intracerebral hemorrhage (ICH) by overcoming blood‐brain barrier limitations, enabling precise, sustained release of neuroprotective and anti‐inflammatory agents. These systems enhance treatment efficacy, but challenges remain in biosafety, drug penetration, and scalability ...
Haojun Shi   +18 more
wiley   +1 more source

Adeno-associated virus delivery of anti-alpha toxin monoclonal antibodies confers protection against Staphylococcus aureus infections. [PDF]

open access: yesPLoS Pathog
Hommes JW   +12 more
europepmc   +1 more source

Purification of a Lethal Toxin of Edwardsiella tarda

open access: yesPurification of a Lethal Toxin of Edwardsiella tarda
openaire  

Anthrax toxin: a tripartite lethal combination.

open access: yesFEBS letters, 2002
Anthrax is a severe bacterial infection that occurs when Bacillus anthracis spores gain access into the body and germinate in macrophages, causing septicemia and toxemia. Anthrax toxin is a binary A-B toxin composed of protective antigen (PA), lethal factor (LF), and edema factor (EF).
ASCENZI P   +5 more
openaire   +6 more sources
Some of the next articles are maybe not open access.

Related searches:

β-Cyclodextrin derivatives that inhibit anthrax lethal toxin

Bioorganic and Medicinal Chemistry, 2006
Recently, we demonstrated that simultaneous blocking of bacterial growth by antibiotics and inhibition of anthrax toxin action with antibodies against protective antigen were beneficial for the treatment of anthrax. The present study examined the hypothesis that blocking the pore formed by protective antigen can inhibit the action of anthrax toxin. The
Vladimir A Karginov   +2 more
exaly   +3 more sources

The Effect of Lethal Toxin on the Respiratory Epithelium. [PDF]

open access: yes, 2008
Inhalational anthrax is an acute infectious disease caused by exposure of the lungs to B. anthracis spores. Alveolar macrophages engulf spores causing them to germinate to the vegetative form of B. anthracis, which secretes edema toxin (ET)and lethal toxin (LT). The pathogenesis of inhalational anthrax is characterized by flu-like symptoms, respiratory
Lehmann, Mandy
openaire   +2 more sources

Proteome analysis of mouse macrophages treated with anthrax lethal toxin

open access: yesBiochimica Et Biophysica Acta - Proteins and Proteomics, 2005
Anthrax toxin produced by bacillus anthracis is a tripartite toxin comprising of protective antigen (PA), lethal factor (LF) and edema factor (EF). PA is the receptor-binding component, which facilitates the entry of LF or EF into the cytosol.
Pradeep K Gupta   +2 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy